|
Delayed
Nasdaq
10:56:43 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.5336 USD | -1.48% |
|
-8.66% | -37.44% |
| 10-14 | Ladenburg Thalmann Initiates Aprea Therapeutics at Buy With $2 Price Target | MT |
| 08-28 | Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APREA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.48% | -8.66% | -37.44% | -64.89% | - | 6.82M |  | | |
- Stock Market
- Stocks
- APRE Stock
- Charts Aprea Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
